InMode Aesthetic Solutions Launches A New Concept for Subdermal Adipose-Remodeling of the Face, EmbraceRF and Morpheus8

InMode Aesthetic Solutions, the leader in cutting edge aesthetic medicine and technology solutions introduces EmbraceRF, a new facial contouring solution that address a treatment gap in current modalities offered to patients. EmbraceRF targets the neck and face through a powerful combination of InMode’s proprietary technologies: FaceTite and Morpheus8.

Not only does EmbraceRF’s new protocol allow plastic surgeons to treat patients that are in the treatment gap category (i.e. not having bad enough skin for a facelift and not good enough skin elasticity for liposuction); but most importantly, introduces a whole new solution to the space. The concept of subdermal adipose-remodeling of the face.

What is adipose-remodeling? The EmbraceRF FaceTite procedure generates heat to “mold” the fat of the face in strategic positions in order to augment the jaw line and rejuvenate the neck. The combination of fat being left strategically behind to contour the face and neck is further augmented by InMode’s newly approved FDA Subdermal Adipose Remodeling Device (SARD): the Morpheus8. The Morpheus8 is applied externally and is the first and only device to mold the fat subdermally in order to morph the aging facial features into a more youthful appearance.

This new concept of facial rejuvenation is unique to EmbraceRF and can only be performed consistently and safely using the synergistic combination FaceTite and Morpheus8. By strategic fat remodeling of the face, a patient can retain the fullness necessary to maintain youthfulness and at the same time tighten skin in the neck and jowl for an optimal result.

The EmbraceRF now provides physicians and patients with the possibility to achieve real permanent surgical results in a 45 minute procedure under local anesthesia in the office. With only a down time of 48 hours, or a long weekend, patients can return to their daily activities in short time. EmbraceRF is one more breakthrough minimally invasive procedure in the tradition of InMode’s benchmark radio-frequency technology. This is a new, one-time procedure, with minimal downtime, and permanent results.

Top physicians Dr Bruce Katz, Dr. Spero Theodorou and Dr. Christopher Khorsandi will host a panel to unveil the new EmbraceRF procedure and share scientific advances and techniques at the 14th annual Vegas Cosmetic Surgery Conference. Physicians can visit InMode at booth #423 for more information.

InMode has set the gold standard for the next generation of contouring devices with unparalleled efficiency resulting in higher revenue for physicians with less time spent in the operating room. As InMode continues to expand its reach across the United States and internationally, the company has developed a close network of world-renowned physicians who have adopted the new state-of-the-art aesthetic solution into their practices.

About InMode: InMode’s technological advancements have become the new standard for aesthetic medicine, specifically in the radio-frequency aesthetic market. For more than three decades our R&D team was critical in developing state-of-the-art light, laser and radio-frequency devices, thereby launching and shaping the industry. Our technology continues that legacy in providing superior satisfaction for both the patient and the practice. Learn more about InMode technologies by visiting www.inmodemd.com.

Behrman Communications
270 Madison Ave. Suite 402
New York, NY 10016

This release was published on openPR.